InvestorsHub Logo

Don'tDrinkTheKoolAid

03/15/16 8:19 AM

#188740 RE: jour_trader #188737

These drugs, often called "abuse-deterrents" are not new. The FDA has approved five of them since 2010, and another 30 are in development, according to The Associated Press.

When I said there were others I was asked for proof here it is.
I have some friends in the pharmacy industry told me specifically to stay away from this stock. I was like I already own it. They said too bad.

Nick Santa

03/15/16 8:30 AM

#188742 RE: jour_trader #188737

It is surprising and sad to hear the FDA, nor anyone in this article, not mention the way to prevent abuse by ingestion. It has nothing to do with the drug. It has everything to do with the physicians ordering them.

For years there has been a urine drug test available by major commercial labs, like Quest Diagnostics, called Prescription Drug Monitoring. It is able to identify abuse by measuring the amount of any drug in a person's system...down to the metabolite level. If you are taking too much or too little of the prescribed drug, then this test will tell you. It will also identify non-prescribed drugs or alcohol still in the system that would suggest abuse is occurring.

There's an agreement involved that the patient signs and agrees to so the physician can test/monitor on a regular basis. You would be surprised how many elderly patients are getting monthly pain pills but not actually taking them. Instead, they give them to family and/or friends, and everyone thinks this is innocent or acceptable.

If every physician in every specialty monitored their patients properly, then the abuse by ingestion epidemic would be greatly reduced. Or another option is requiring only certain types of doctors the ability to prescribe drugs that can be abused, while also requiring them to drug test patients monthly. Then ADT drugs would be what they are now...part of the solution.

So ADT and ART is not going anywhere because the real solution to the epidemic lies within the four walls of your doctor's office.